FMS Stock Ownership Activity
FRESENIUS MEDICAL CARE-ADR 13F holders
No value investing guru has made any change to the FRESENIUS MEDICAL CARE-ADR (FMS) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying FMS now?
According to the latest SEC filing(s) FRESENIUS MEDICAL CARE-ADR (FMS) has not been purchased by any super investor.
To see more about who is investing in FRESENIUS MEDICAL CARE-ADR (FMS), please go to the FMS ownership page.
2023 Q3
(1 result)
Current price: $20.10
16.01%
Reported price*: $23.93
2023 Q2
(1 result)
Current price: $20.10
16.01%
Reported price*: $23.93
2023 Q1
(1 result)
Current price: $20.10
5.46%
Reported price*: $21.26
2022 Q4
(1 result)
Current price: $20.10
23.01%
Reported price*: $16.34
2022 Q3
(1 result)
Current price: $20.10
43.16%
Reported price*: $14.04
2022 Q2
(1 result)
Current price: $20.10
19.41%
Reported price*: $24.94
2022 Q1
(1 result)
Current price: $20.10
40.32%
Reported price*: $33.68
2021 Q4
(1 result)
Current price: $20.10
38.08%
Reported price*: $32.46
2021 Q3
(1 result)
Current price: $20.10
42.52%
Reported price*: $34.97
2021 Q2
(1 result)
Current price: $20.10
51.65%
Reported price*: $41.57
2021 Q1
(1 result)
Current price: $20.10
45.50%
Reported price*: $36.88
11 of 11
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.